Loading clinical trials...
Loading clinical trials...
A Randomized Phase III Trial of Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG Regimen for Stage I-III Pancreatic Ductal Adenocarcinoma (PDAC)
Conditions
Interventions
PAXG
mFOLFIRINOX
+2 more
Locations
22
Italy
Oncologia Medica e Prevenzione Oncologica Centro di riferimento oncologico (CRO), IRCCS
Aviano, Italy
Oncologia Medica Az. Ospedaliera Istituto Tumori "Giovanni Paolo II"
Bari, Italy
Oncologia ASST pg23
Bergamo, Italy
Oncologia Medica Azienda Universitaria Ospedaliera Policlinico Sant'Orsola-Malpighi
Bologna, Italy
Oncologia Medica dell'Az.Ospedaliera Fondazione Poliambulanza Istituto Ospedaliero
Brescia, Italy
Oncologia Medica AOU Careggi
Florence, Italy
Start Date
November 3, 2020
Primary Completion Date
March 15, 2025
Completion Date
January 31, 2026
Last Updated
April 9, 2025
Lead Sponsor
Associazione Italiana per lo Studio del Pancreas
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions